Editorial: Allostatic Load and Inflammatory Bowel Disease. Authors' Reply

被引：0
|
作者：
Zhao, Jianhui [1 ,2 ]
Xue, Erxu [3 ]
Liu, Zhanju [4 ,5 ]
Li, Xue [1 ,2 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Big Data Hlth Sci, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Sch Publ Hlth, Hangzhou, Zhejiang, Peoples R China
[3] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Nursing Dept, Hangzhou, Zhejiang, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Inflammatory Bowel Dis Res, Shanghai, Peoples R China
[5] Tongji Univ, Shanghai Peoples Hosp 10, Sch Med, Dept Gastroenterol, Shanghai, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2025年 / 61卷 / 01期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1111/apt.18414
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：190 / 191
页数：2
相关论文
共 50 条
  • [21] Editorial: probiotics in inflammatory bowel disease-wrong organisms, wrong disease, or flawed concepts? Authors' reply
    Gracie, D. J.
    Derwa, Y.
    Hamlin, P. J.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (06) : 633 - 634
  • [22] Editorial: investigating the association between sweetened beverages and risk of inflammatory bowel disease-authors' reply
    Fu, Tian
    Wang, Xiaoyan
    Chen, Jie
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (06) : 1088 - 1089
  • [23] The changing epidemiology of paediatric inflammatory bowel disease: authors' reply
    Chouraki, V.
    Turck, D.
    Colombel, J. -F.
    Gower-Rousseau, C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (12) : 1381 - 1382
  • [24] Editorial: vedolizumab in inflammatory bowel diseases-less is more? Authors' reply
    Danese, Silvio
    Subramaniam, Kavitha
    Van Zyl, Jan
    Adsul, Shashi
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (03) : 445 - 446
  • [25] Editorial: type D personality and its relationship with depression and disease activity in inflammatory bowel disease-authors' reply
    Jordi, Sebastian Bruno Ulrich
    Misselwitz, Benjamin
    Begre, Stefan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 54 (01) : 82 - 83
  • [26] Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply
    Tannoury, Jenny
    Amiot, Aurelien
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (12) : 1323 - 1323
  • [27] Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease-authors' reply
    Colman, Ruben J.
    Minar, Phillip
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (05) : 567 - 568
  • [28] Letter: diagnostic delay in inflammatory bowel disease-Authors' reply
    Pollok, Richard
    Baillie, Samantha
    Jayasooriya, Nishani
    Blackwell, Jonathan
    Petersen, Irene
    Bottle, Alex
    Saxena, Sonia
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (10) : 1205 - 1206
  • [29] Letter: pancreatic involvement in inflammatory bowel disease-authors' reply
    Massironi, Sara
    Vigano, Chiara
    Danese, Silvio
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (02) : 371 - 371
  • [30] Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis - Authors' reply
    Bravo, Luis E.
    Bravo, Juan C.
    Piazuelo, Maria Blanca
    Camargo, Maria Constanza
    Correa, Pelayo
    GUT, 2007, 56 (03) : 436 - 436
12345